For a year, the Trump administration has touted the wealth-building potential of the accounts. Babies born between 2025 and ...
Jersey Mike’s Subs on Thursday publicly filed its IPO paperwork, a move that brings the sandwich chain closer to a ...
Grabbing an employer match is essential, but prioritizing high-interest debt and emergency cash can bring much better ...
The S&P 500 could be headed for a choppier phase after its rebound of more than 20% from the recent Iran war lows, according to a midyear update from Truist. "The bull market still deserves the ...
Stocks ended mixed Thursday after a tepid jobs report for June reflected only modest hiring and an OK U.S. economy. The Dow ...
The June jobs report is worse than many people realize. Meanwhile, the campaign is gathering steam to get the Federal Reserve ...
The chief executive officer of Seer has offered to buy the company for $2.45 a share in cash, plus two contingent value rights, the biotechnology company said. Seer on Thursday said that CEO Omid ...
VivoPower said it will refocus the company on its artificial intelligence data center business and move ahead with separating two non-core units, Tembo and Caret Digital, in line with that strategy.
Scribe Therapeutics filed for an initial public offering. The biotechnology company didn't say how many shares it would offer or at what price, and said the underwriters have a 30-day option to buy ...
Ecolab updated its guidance after closing its $4.75 billion acquisition of CoolIT Systems, a data center liquid cooling company. The water treatment and sanitation company on Thursday said it expects ...
Health-care companies rose as traders continued to rotate out of high-risk artificial-intelligence stocks into lagging sectors. Shares of Moderna added to recent gains amid optimism the vaccine ...
Shares of energy companies ticked up alongside oil futures. Oil futures rose 11 cents to $68.69 a barrel but retreated for the fourth consecutive week amid signs that Middle East energy exports were ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results